
OpenAI and Novo Nordisk Team Up to Speed Drug Discovery
OpenAI is partnering with pharmaceutical giant Novo Nordisk to use AI for discovering new medicines faster. The collaboration aims to supercharge scientists, not replace them, while tackling everything from drug discovery to supply chain efficiency.

